Objective
to compare a delayed and very early invasive strategy in patients with non-ST- segment elevation in ACS without pre-treatment
Study
prospective, open-label, randomised trial
Population
patients with intermediate high-risk NSTE-ACS intended for invasive approach. Delayed strategy: coronary angiography 12 to 72 h after randomisation. Very early strategy: coronary angiography within 2 h.
Endpoints
composite of cardiovascular death and recurrent ischaemic events at 1 month
Conclusion
a very early invasive strategy was associated with significant less events compared to a delayed strategy in patients with non ST-segment elevation ACS
Lemesle et al. J Am Coll Cardiol Intv. 2020;13:907-17
